Table 2 Management in the ICU of the overall cohort of IPH

Acute heart failure, n (%)

11 (14)

6 (26)

5 (9)

ns

Vasopressive support during the first 24 h, n (%)

39 (51)

21 (91)

18 (33)

<0.001

17.8

(3.7–84.2)

 Norepinephrine, n

25

16

9

 Epinephrine, n

11

5

6

 Dobutamine, n

5

2

3

Liver failure (factor V < 50 % or jaundice), n (%)

16 (21)

12 (52)

4 (7)

<0.001

1.6

(3.6–50)

Acute kidney injury, n (%)

42 (55)

19 (83)

23 (43)

0.001

6.4

(1.9–21.3)

 Dialysis, n

19

10

9

 Hemofiltration, n

4

2

2

 Renal recovery at ICU discharge, n

14

1

13

 Duration of renal replacement therapy, days

15.8 ± 16.9

18.1 ± 21.1

5.3 ± 5.4

0.01

Mechanical ventilation, n (%)

49 (63)

22 (96)

27 (50)

<0.001

22

(2.7–175)

Duration of mechanical ventilation, days

3 (0–10.5)

6 (2–21)

1 (1–8)

0.002

Packed red blood cell transfusion, units

4 (2–6)

6 (3–8)

3(2–5)

0.002

Conservative treatment, n (%)

53 (69)

11 (48)

42 (78)

0.007

0.24

(0.08–0.68)

Surgery, n (%)

7 (9)

6 (26)

1 (2)

0.002

18.7

(2.1–166.5)

Embolization, n (%)

17 (22)

6 (26)

11 (20)

ns